Now showing items 1-2 of 2

    • R&D costs and returns by therapeutic category 

      Dimasi, JA; Grabowski, HG; Vernon, J (Drug Information Journal, 2004-09-03)
      Objectives: This study examines the degree to which therapeutic class accounts for variability in drug development costs. It also scrutinizes how sales levels vary across the associated therapeutic classes for those drugs ...
    • The distribution of sales revenues from pharmaceutical innovation. 

      Grabowski, HG; Vernon, J (Pharmacoeconomics, 2000)
      OBJECTIVE: This report updates our earlier work on the returns to pharmaceutical research and development (R&D) in the US (1980 to 1984), which showed that the returns distributions are highly skewed. It evaluates a more ...